lyophilized sterile fecal filtrate
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 14, 2018 (NCT03353506)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03806803 | Phase 2 | Mar 21, 2019 | McGill University, University of Alberta, University of British Columbia, University of Calgary |
| NCT03353506 | Phase 2 | Feb 14, 2018 | University of Alberta |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alberta | Academic/Hospital | 2 | 2 | 1 | 2018 |
| McGill University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Calgary | Academic/Hospital | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1